Related Experiment Video
Updated: May 16, 2026
08:27
Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
Published on: September 27, 2019
[Analysis of GRACE principle for comparative effectiveness research].
1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing.
Summary
Comparative Effectiveness Research (CER) is gaining traction globally. This study analyzes the Good Research for Comparative Effectiveness (GRACE) standards to guide observational studies in Chinese medicine.
Area of Science:
- Health Services Research
- Pharmacoeconomics
- Traditional Chinese Medicine
Context:
- Comparative Effectiveness Research (CER) is a significant concept in international healthcare reform.
- CER focuses on policy orientation at the national medical system level.
- International organizations have provided guidelines for CER design and reporting, but assessment standards are lacking.
Purpose:
- To analyze the Good Research for Comparative Effectiveness (GRACE) standards.
- To provide referential standards for conducting observational studies.
- To introduce CER principles into clinical studies of Chinese medicine.
Summary:
- The study examines the GRACE initiative by the International Society Pharmacoepidemiology.
- GRACE provides standard rules for assessing observational studies.
- This analysis aims to establish benchmarks for CER implementation in Chinese medicine.
Impact:
- Enhance the quality and reliability of observational studies in Chinese medicine.
- Facilitate evidence-based decision-making in healthcare policy.
- Promote the integration of traditional Chinese medicine into global healthcare systems.
Related Concept Videos
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Bioequivalence Data: Statistical Interpretation
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:16Bioequivalence: Overview
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...